Lazar David E. 13D/13G Filings for Indaptus Therapeutics, Inc. (INDP)

Lazar David E. 13D and 13G filings for Indaptus Therapeutics, Inc.:

  • Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
  • Shares have been adjusted for stock splits.
Time period
Reported
DateTime
Transaction
Date
TypeCompany
Symbol
Filed By
Symbol
Shares Owned
% Owned
Shares Vs. Prev ReportView
2026-03-24
4:05 pm
Sale
2026-03-2313DINDAPTUS THERAPEUTICS INC
INDP
Lazar David E.2,064,000
47.930%
-108,936,000decrease
(-98.14%)
Filing
2026-03-02
5:20 pm
Purchase
2026-02-2613DINDAPTUS THERAPEUTICS INC
INDP
Lazar David E.111,000,000
98.000%
111,000,000increase
(New Position)
Filing